-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BngmkJBFmt3AGIJBriYEc7UpT9XlQ3yg2J9mQ/vTFeZg+iJ2nonDHzkbLydLycqP UNy+fYjBa+DeR958moYzWw== 0000950153-97-001240.txt : 19971124 0000950153-97-001240.hdr.sgml : 19971124 ACCESSION NUMBER: 0000950153-97-001240 CONFORMED SUBMISSION TYPE: 11-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961231 FILED AS OF DATE: 19971121 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICIS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000859368 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521574808 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 11-K SEC ACT: SEC FILE NUMBER: 000-18443 FILM NUMBER: 97726286 BUSINESS ADDRESS: STREET 1: 4343 EAST CAMELBACK RD CITY: PHOENIX STATE: AZ ZIP: 85018 BUSINESS PHONE: 2125992000 MAIL ADDRESS: STREET 1: 4343 E CAMELBACK RD STREET 2: SUITE 250 CITY: PHOENIX STATE: AZ ZIP: 85018 11-K 1 FORM 11-K 1 COMPANY DATA: COMPANY CONFORMED NAME: MEDICIS PHARMACEUTICAL CORPORATION CENTRAL INDEX KEY: [ ] STANDARD INDUSTRIAL CLASSIFICATION 2834 IRS NUMBER: 52-1574808 STATE OF INCORPORATION: DELAWARE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 11-K SEC ACT: 1933 Act SEC FILE NUMBER: 333- FILM NUMBER: BUSINESS ADDRESS: STREET 1: 4343 EAST CAMELBACK ROAD STREET 2: SUITE 250 CITY: PHOENIX STATE: ARIZONA ZIP: 85018 BUSINESS PHONE: 602-808-8800 MAIL ADDRESS: STREET 1: 4343 EAST CAMELBACK ROAD STREET 2: SUITE 250 CITY: PHOENIX STATE: ARIZONA ZIP: 85018 As filed with the Securities and Exchange Commission on November 21, 1997 Registration No. 333- ________________________ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (X) ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the plan year ended December 31, 1996 or ( ) TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: Full title of the plan and the address of the plan, if different from that of the issuer named below: Medicis Pharmaceutical Corporation 401(k) Plan Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: Medicis Pharmaceutical Corporation 4343 East Camelback Road, Suite 250 Phoenix, Arizona 85018 2 MEDICIS PHARMACEUTICAL CORPORATION 401(K) PLAN FINANCIAL STATEMENTS STATEMENT OF ASSETS AND LIABILITIES FOR THE PLAN YEAR ENDED DECEMBER 31, 1996
ASSETS BEGINNING OF YEAR END OF YEAR Cash ....................................... $ 58,328 $ 45,224 Investments: Corporate Debt and Equity Instruments . 323,115 557,722 Loans to Participants 17,400 25,849 -------- -------- TOTAL ASSETS .......................... $398,843 $628,795 ======== ======== LIABILITIES Payables ................................... 0 0 Acquisition indebtedness ................... 0 0 Other liabilities .......................... 0 0 -------- -------- TOTAL LIABILITIES .............. $ 0 $ 0 ======== ======== NET ASSETS ..................... $398,843 $628,795
INCOME STATEMENT FOR THE PLAN YEARS ENDED DECEMBER 31, 1996
INCOME AMOUNT TOTAL Contributions received or receivable in cash from: Employees ............................................... $191,388 Participants Rollovers/Transfers ........................ 26,481 Earnings from investments (interest, dividends, rents, royalties) .. 2,518 Other Income - unrealized appreciation ............................. 67,868 -------- TOTAL INCOME $288,255 ======== EXPENSES Distribution of benefits and payments to provide benefits directly to $ 58,303 participants or their beneficiaries ................................. TOTAL EXPENSES ......................................... $ 58,303 ======== NET INCOME ............................................. $229,952
3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Medicis Pharmaceutical Corporation, as Plan Administrator with respect to the Medicis Pharmaceutical Corporation 401(k) Plan, has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized. MEDICIS PHARMACEUTICAL CORPORATION 401(k) PLAN Date: November 21, 1997. By: /s/ Mark A. Prygocki,Sr. ------------------------- Mark A. Prygocki, Sr., Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----